Veristat Advances Game-Changing Pain and Inflammation Therapy
Veristat continues to support Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and...
Posts about
Therapeutic Areas of Expertise
Veristat Strengthens Clinical Operations Capabilities - Acquires Topstone Research
Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma
Veristat Congratulates Agios on the FDA Approval of TIBSOVO®
The First Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
SOUTHBOROUGH, MA – ...
Veristat’s Collaboration with Aegerion Contributes to FDA Approval of Juxtapid™
Veristat’s Strategic Guidance Contributes to Successful Approval of Aegerion’s Novel Drug Juxtapid